Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
The Alloimmune Disorders of Pregnancy
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
Linda Bradley, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Melissa Simon, MD
Samantha Denäe
Casey Joe Hinds
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Clinical Considerations for the Diagnosis of Endometriosis
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Pre- and Postoperative Use of GnRH Antagonists
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Alexandra Benachi, MD, PhD
Julien Zuber, MD, PhD
Alloimmune Neutropenia of the Fetus and Newborn
Masja de Haas, MD, PhD
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.